Best Practice Fragile X Testing and Analysis Guidelines for Australasian Laboratories

Best Practice Fragile X Testing & Analysis Guidelines for Australasian Laboratories

Newborn Bloodspot Screening

Joint RACP-HGSA Newborn Bloodspot Screening Policy

Cystic Fibrosis Population Screening

Cystic Fibrosis Population Screening

Pre-symptomatic and Predictive Testing in Children and Young People

Pre-Symptomatic & Predictive Testing in Children & Young People

Prenatal screening tests for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and neural tube defects

Prenatal Screening Tests for Trisomy 21, Trisomy 18 & Neural Tube Defects

Genetic Testing and Sport Performance

Genetic Testing and Sports Performance

Parental Consent to the Paternity Testing of Children For Non-Clinical Purposes

The HGSA recommends that consent from both parents should be obtained in paternity testing of children.

Continue Reading...

Prenatal Diagnosis

Prenatal Diagnosis

Presymptomatic and Predictive Testing for Genetic Disorders

Presymptomatic and predictive testing refers to a test performed on a person with a family history of a heritable disorder and who lacks symptoms or signs of the disorder with the objective being to determine whether the person has inherited the mutation responsible.

Continue Reading...

Retention, Storage and Use of Sample Cards from Newborn Screening Programs

Retention, Storage and Use of Newborn Screening Cards

Direct to Consumer Genetic Testing

Direct to Consumer Genetic Testing

Structure of Clinical Genetics Units in Australia

Structure of Clinical Genetics Units in Australia

Prioritising Genetic Tests

Prioritising Genetic Tests